1/99
Comprehensive vocabulary flashcards reviewing fed-state protein metabolism through fasted-state metabolic regulations, pathways, transporters, and calculations for Exam 3.
Gluconeogenesis Induction Timing
Anabolic pathway turned ON during a prolonged fast of at least 18–20 hrs since the last meal, requiring high rates of fatty acid oxidation to proceed.
Pyruvate Carboxylase
The first enzyme in gluconeogenesis that converts pyruvate to oxaloacetate; requires acetyl-CoA as its obligatory allosteric activator.
Fasting Respiratory Exchange Ratio (RER)
An RER value close to 0.7, which reflects high rates of fatty acid oxidation meeting cellular ATP demand during prolonged fasting.
Glycerol (Gluconeogenic Substrate)
Three-carbon backbone released from adipose triglyceride breakdown that enters gluconeogenesis by being converted into glycerol 3-phosphate.
Lactate (Gluconeogenic Substrate)
Non-carbohydrate carbon source easily converted back into pyruvate by the enzyme lactate dehydrogenase to enter gluconeogenesis.
Amino Acid Carbon Skeletons (Gluconeogenesis)
Substrates that enter gluconeogenesis as pyruvate or TCA cycle intermediates, which are converted to oxaloacetate and subsequently synthesized into glucose.
Glucose-6-Phosphate Dehydrogenase
The primary regulated enzyme of the pentose phosphate pathway that produces NADPH.
6-Phosphogluconate Dehydrogenase
The secondary enzyme of the pentose phosphate pathway that generates NADPH.
Malic Enzyme
A standalone enzyme that provides an alternative cellular pathway to produce NADPH.
Cholesterol Synthesis (NADPH Requirement)
An anabolic biosynthetic pathway that requires reducing equivalents from NADPH to build cholesterol molecules.
De Novo Fatty Acid Synthesis (NADPH Requirement)
A pathway active in the fed state that requires NADPH as an electron donor to synthesize new fatty acids from acetyl-CoA.
Steroid Hydroxylase Reactions
Enzymatic reactions that utilize NADPH to convert cholesterol into steroid hormones, including estrogen, progesterone, and aldosterone.
NADPH Oxidase Reactions
Enzymatic reactions that utilize NADPH to generate reactive oxygen species.
Glutathione Reductase
An enzyme that requires NADPH to reduce oxidized glutathione back into its active, protective reduced form.
Tetrahydrofolate Conversion
The metabolic reaction that uses NADPH to convert folate into its bioactive coenzyme form, tetrahydrofolate.
Nitric Oxide Synthesis
The enzymatic synthesis of nitric oxide from amino acid precursors, which requires NADPH as an essential cofactor.
Protein Turnover
The continuous process in which body proteins are continually degraded and resynthesized based on metabolic needs.
Nonprotein Amino Acid Derivatives
Nitrogen-containing compounds synthesized from amino acids whose production will always occur regardless of nutritional state.
Stomach Protein Turnover Rate
Approximately 40%/day, representing the highest turnover rate among listed tissues due to high transcription and translation activity.
Esophagus Protein Turnover Rate
Approximately 30%/day, representing the second highest rate of tissue protein turnover.
Liver Protein Turnover Rate
Approximately 20%/day, reflecting rapid synthesis and degradation of regulatory and secretory proteins.
Colon Protein Turnover Rate
Approximately 10%/day, representing an intermediate rate of digestive tract protein turnover.
Lymphocyte Protein Turnover Rate
Approximately 7%/day, reflecting the protein turnover rate of circulating immune cells.
Heart Protein Turnover Rate
Approximately 5%/day, representing steady protein turnover in cardiac muscle.
Skeletal Muscle Protein Turnover Rate
Approximately 1–2%/day, representing the lowest tissue rate due to low rates of cell replication.
Limiting Amino Acid Theory
The principle stating that if just one type of amino acid is missing from the amino acid pool, protein synthesis will completely stop.
Limiting Amino Acid
The amino acid present in the smallest quantity within the amino acid pool; it can be any amino acid and is not always an essential one.
Hexosamine Biosynthetic Pathway
A nutrient-sensing pathway upregulated in an overfed state without energy demand that requires proteins, glucose, lipid-derived acetyl-CoA, energy, and nucleotides.
O-GlcNAc (N-Acetylglucosamine)
The product of the hexosamine biosynthetic pathway that attaches to proteins and enzymes via covalent bonds as a post-translational modification.
O-GlcNAcase (OGA)
The specific enzyme responsible for removing N-acetylglucosamine (O-GlcNAc) from proteins.
O-GlcNAc Transferase (OGT)
The specific enzyme responsible for adding N-acetylglucosamine (O-GlcNAc) to target proteins.
Overfed State Metabolic Upregulations
Simultaneous upregulation of de novo fatty acid synthesis, glycerol synthesis, triglyceride synthesis, and the hexosamine biosynthetic pathway in conditions of nutrient excess.
Catecholamines
Hormones released from the adrenal medulla during stress, exercise, or fasting that bind to adrenergic receptors on target tissues like adipocytes.
Beta-Adrenergic Receptors (Adipocyte)
Receptors that engage a stimulatory G-protein to activate adenylyl cyclase and PKA, turning lipolysis and glycogenolysis ON and making cells more lipolytically active.
Adenylyl Cyclase (AC)
Enzyme activated downstream of beta-adrenergic receptor stimulatory G-proteins that converts ATP into cAMP.
Protein Kinase A (PKA) Lipolytic Targets
Kinase activated by cAMP that phosphorylates CGI-58, hormone-sensitive lipase (HSL), adipose triglyceride lipase (ATGL), and perilipin.
Perilipin
Lipid droplet regulatory protein that binds CGI-58 when unphosphorylated and releases CGI-58 upon PKA phosphorylation to enable lipolysis.
CGI-58
Co-regulatory protein released from phosphorylated perilipin that binds to ATGL and increases its enzymatic activity.
Adipose Triglyceride Lipase (ATGL)
Lipolytic enzyme that hydrolyzes triglycerides to diglycerides; activated when phosphorylated and associated with CGI-58.
Hormone-Sensitive Lipase (HSL)
Lipolytic enzyme that hydrolyzes diglycerides to monoglycerides; active when phosphorylated by PKA and allosterically inhibited by fatty acyl-CoAs.
Monoacylglycerol Lipase (MAGL)
Enzyme that converts monoglycerides to glycerol and free fatty acids; it is not regulated via phosphorylation.
Adipocyte Glycerol Kinase Deficiency
The absence of glycerol kinase in adipocytes, preventing rephosphorylation of glycerol to glycerol-3-phosphate and necessitating free glycerol export to the liver.
Alpha-Adrenergic Receptors (Adipocyte)
Receptors that engage an inhibitory G-protein to block adenylyl cyclase, preventing cAMP generation, halting PKA phosphorylation, and turning lipolysis OFF.
Beta-Cell Anaplerotic Reactions
Uptake of amino acids like leucine and glutamine that replenish TCA cycle intermediates, increasing ATP generation and raising the ATP:ADP ratio.
Beta-Cell ATP:ADP Ratio Mechanism
An elevated ATP:ADP ratio closes ATP-sensitive K+ channels, preventing K+ efflux, causing membrane depolarization, Ca2+ entry, and insulin secretion.
ATP-Sensitive K+ Channels
Potassium channels in pancreatic beta cells that close in response to high ATP, preventing K+ transport and initiating cell membrane depolarization.
Na+-Dependent Amino Acid Co-Transport
Entry of neutral amino acids (such as alanine and proline) into beta cells alongside positively charged Na+ ions, causing membrane depolarization and insulin exocytosis.
Cationic Amino Acid Transport (Beta Cells)
Direct influx of positively charged amino acids (arginine and lysine) carrying net positive charge into cytosol, raising membrane potential to trigger insulin release.
Voltage-Gated Ca2+ Channels (Beta Cells)
Membrane channels opened by depolarization that allow extracellular Ca2+ influx, triggering exocytosis of insulin secretory granules.
Leucine (Muscle Signaling)
An essential amino acid that enters lysosomes to trigger the intracellular signaling cascade that initiates muscle protein synthesis.
RagA GTPase
G-protein that loads with GTP inside the lysosome to translocate mTORC1 from cytosol to the lysosomal surface; in its GDP-bound form, it inactivates mTOR.
Lysosome (mTOR Signaling Hub)
The essential organellar platform where amino acid signaling concentrates and activates mTORC1.
Maximal Muscle Protein Synthesis Stimuli
The combined, additive effect of amino acids, insulin, and IGF acting together to achieve maximum muscle protein synthesis.
mTOR Catabolic Targets
Master regulatory kinase that stimulates protein synthesis and inhibits protein degradation pathways (ubiquitin-proteasome pathway and autophagy-lysosomal system).
Ubiquitin-Proteasome and Autophagy-Lysosomal Systems
The two primary protein degradation pathways inhibited by active mTOR, which become active during fasting and prolonged fasting (24–48 hrs).
PI3K/Akt Pathway (Fed State Signaling)
Downstream insulin signaling cascade in the fed state that blocks TSC, allowing Rheb-GTP to activate protein translation.
Tuberous Sclerosis Complex (TSC)
Regulatory complex that blocks Rheb-GTP; inhibited by insulin via Akt, but phosphorylated and activated by AMPK to shut off protein synthesis.
Rheb-GTP
G-protein that provides the necessary energy for protein translation when liberated from TSC inhibition.
AMP-Activated Protein Kinase (AMPK)
Energy sensor activated during low nutrient/energy states when the AMP:ATP ratio is high, acting to turn energy-expensive synthesis pathways OFF.
AMPK Activation Mechanisms
Direct allosteric activation by elevated AMP when ATP decreases, and covalent phosphorylation by PKA downstream of glucagon and catecholamines.
AMPK Regulation of TSC and mTOR
Active AMPK phosphorylates and activates TSC (blocking Rheb) and directly phosphorylates and inhibits mTOR to halt protein synthesis.
Fasted State Lipolysis
Metabolic pathway turned ON in the fasted state; fatty acids become the primary substrate for energy.
Fasted State Beta-Oxidation
Metabolic pathway turned ON in the fasted state that breaks fatty acid molecules down in mitochondria and cytosol to generate ATP.
Regular Fast Glycogenolysis
Pathway turned ON during a regular fast where liver glycogen is broken down into glucose to maintain blood glucose homeostasis.
Prolonged Fast Gluconeogenesis
Anabolic pathway turned ON in a prolonged fast (≥18–20 hrs) where the body synthesizes new glucose from non-carbohydrate carbon sources.
Ketone Bodies
Circulating energy compounds (acetoacetate, beta-hydroxybutyrate, and acetone) synthesized from acetyl-CoA in liver mitochondria during a prolonged fast.
Cortisol (Prolonged Fast)
Hormone turned ON during a prolonged fast (24–48 hrs) that actively drives bodily proteolysis, accompanied by an active urea cycle.
Fasting Circulating Lipoproteins
Lipoproteins found circulating in the blood during the fasted state, specifically VLDLs and LDLs.
GLUT 1 Transporter
Low-Km glucose transporter expressed in almost all cells that provides basal glucose uptake and serves as the major active GLUT in the fasted state.
GLUT 4 Transporter
Insulin-stimulated glucose transporter housed intracellularly that is not active or present on the cell surface in the fasted state.
GLUT 2 Transporter
High-Km glucose transporter that is NOT active for glucose uptake in the fasted state.
GLUT 3 Transporter
High-affinity glucose transporter expressed in the brain that is always active to ensure continuous glucose supply.
Albumin (Fatty Acid Transport)
Blood protein that binds and transports free fatty acids liberated from adipose lipolysis to target tissues like muscle and liver.
FATP and FABP Transporters
Fatty acid transport proteins present and active on the muscle cell membrane in the fasted state to import free fatty acids into cytosol.
FAT/CD36 Transporter
Insulin-stimulated fatty acid transporter that is recessed from the plasma membrane and sequestered intracellularly in the fasted state.
Carnitine Shuttle System
The key regulatory transport mechanism required for long-chain fatty acids to cross the mitochondrial membrane for beta-oxidation.
Carnitine Palmitoyltransferase 1 (CPT1)
Outer mitochondrial enzyme that removes CoA and attaches carnitine to fatty acids; allosterically inhibited by malonyl-CoA.
Acyl-Carnitine Translocase
Transporter on the inner mitochondrial membrane that carries acyl-carnitine into the matrix and exports free carnitine.
Carnitine Palmitoyltransferase 2 (CPT2)
Inner mitochondrial matrix enzyme that removes carnitine and attaches CoA back onto the fatty acid for beta-oxidation.
Malonyl-CoA (CPT1 Regulation)
Biosynthetic intermediate whose accumulation allosterically inhibits CPT1, blocking fatty acid entry into the mitochondria and preventing beta-oxidation.
Insulin Dephosphorylation Mechanism
Fed-state signaling where insulin promotes dephosphorylation of metabolic enzymes via downstream protein phosphatases (PP1, PP2, PP4).
Insulin Transcriptional Regulation
Long-term regulation wherein insulin increases transcription of glucokinase, PFK1, and pyruvate kinase, and decreases transcription of G6Pase and PEPCK.
Glucagon Signaling Mechanism
Fasting hormone released during low blood glucose that stimulates phosphorylation of target metabolic enzymes via PKA.
Hexokinase Product Inhibition
Glycolytic enzyme that is allosterically inhibited by its product, glucose-6-phosphate (G6P); turned OFF in a fasted state.
Glucokinase Regulatory Protein (GKRP)
Regulatory protein that sequesters glucokinase upon fructose-6-phosphate buildup and releases glucokinase upon glucose buildup; OFF in fasting.
Phosphofructokinase-1 (PFK1) Regulation
Glycolytic enzyme allosterically activated by F26BP, AMP, and ADP, and allosterically inhibited by ATP and citrate; turned OFF in the fasted state.
Liver Pyruvate Kinase Regulation
Enzyme allosterically activated by F16BP, inhibited by ATP, alanine, and acetyl-CoA, and inactivated by PKA phosphorylation in the liver; OFF in fasting.
Glycogen Synthase Regulation
Enzyme phosphorylated and inhibited by 5 kinases (GSK3, GPK, PKA, CaMK, AMPK); activated by protein phosphatases and allosterically by G6P; OFF in fasting.
Muscle vs. Liver Glycogen Fate
Muscle glycogen is trapped as G6P for local glycolysis and ATP synthesis; liver expresses glucose-6-phosphatase to release free glucose into the blood.
Liver Glycogen Phosphorylase Regulation
Active when phosphorylated by GPK; has no allosteric activators, is allosterically inhibited by glucose, and is deactivated by PP1; ON in fasting.
Muscle Glycogen Phosphorylase Regulation
Activated allosterically by AMP (inhibited form) and inorganic phosphate (Pi, both forms), and allosterically inhibited by G6P; ON in fasting.
Acetylation of Glycogen Phosphorylase
Post-translational modification that attracts PP1 to decrease glycogen phosphorylase activity, signaling that cellular energy needs are met.
Glycogen Phosphorylase Kinase (GPK) Activation
Activated by PKA phosphorylation and maximally active when bound to Ca2+ (from SR in contracting muscle or smooth ER in liver via epinephrine); ON in fasting.
Adipose Phosphodiesterase (PDE)
Adipose enzyme activated downstream of insulin that converts cAMP to AMP, blocking PKA to turn lipolysis OFF; turned OFF in the fasted state.
Glycerol-3-Phosphate Acyltransferase (GPAT)
Triglyceride synthesis enzyme that is phosphorylated and turned OFF by AMPK in the fasted state.
HMG-CoA Reductase Regulation
Rate-limiting enzyme of cholesterol synthesis that is phosphorylated and turned OFF by AMPK, and allosterically inhibited by cholesterol; OFF in fasting.
Acetyl-CoA Carboxylase (ACC) Regulation
De novo fatty acid synthesis enzyme that is phosphorylated and turned OFF by AMPK in the fasted state.
Malonyl-CoA Decarboxylase (MCD)
Enzyme phosphorylated and turned ON by AMPK that converts malonyl-CoA back to acetyl-CoA, relieving CPT1 inhibition and enabling beta-oxidation.
Fructose 1,6-Bisphosphatase Regulation
Gluconeogenic enzyme that is allosterically inhibited by AMP and fructose-2,6-bisphosphate (F26BP); turned ON in a prolonged fast.
Saturated Fatty Acid ATP Calculation Formula
Carbons divided by 2 yields acetyl-CoAs (×10 ATP); beta-oxidation cycles equal acetyl-CoAs minus 1 (×4 ATP from 1 FADH2+1 NADH); sum gross ATP and subtract 2 ATP used for activation.